As research yields new insights and potential therapies, the market is expected to benefit from a pipeline of novel products that could reshape treatment paradigms
5.3 Manifestations of neuropsychiatric system injury Ketamine abuse commonly manifests as dissociative symptoms, such as altered consciousness, detachment from the environment, and sensory loss (Vlisides et al., 2018)
Oral tirzepatide is not FDA-approved, and there are no clinical trials to tell us how effective oral tirzepatide is
Know the FDA-approved forms of medication: Oral drops, gummies, patches and sprays are fraudulent forms of GLP-1s and are not FDA-approved
While the use of cost and efficacy ratios rather than absolute differences mitigated the effect of this on the presentation of results, the differing follow-up periods should be considered in the interpretation and potential extrapolation of the outcomes
The other authors declare no other funding relevant to this work